Convalescent Plasma: Why, How, and Lessons Learned
Interview with Jeffrey Winters, M.D. In this episode, Jeffrey Winters, M.D., Vice Chair of the Division of Transfusion Medicine at Mayo Clinic, discusses the convalescent plasma program for COVID-19 treatment.
Lab Medicine Rounds · Mayo Clinic Laboratories
Audio is streamed directly from the publisher (media.transistor.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Time Stamps
00:00 Podcast Intro
00:39 What is they ‘why’ behind starting up a convalescent plasma program?
04:00 If physicians are taking care of a patient and wanting to get this product how do they go about it?
11:23 With the Expanded Access Protocol and Emergency IND, how many products does that get for the given patient?
13:00 Where should we direct people who are interested in being a donor?
14:51 Can you give us an idea on who would be eligible to donate convalescent plasma?
17:16 What are some lessons learned from your perspective as you have navigated through COVID-19 and the dynamic situation?
Resources: